Showing 181 - 200 results of 1,727 for search '"Fibrosis"', query time: 0.06s Refine Results
  1. 181
  2. 182

    Serum Hepcidin Level as a Marker of Iron Status in Children with Cystic Fibrosis by Monika Kałużna-Czyż, Urszula Grzybowska-Chlebowczyk, Halina Woś, Sabina Więcek

    Published 2018-01-01
    “…Iron deficiency is common in patients with cystic fibrosis. Conventional iron status markers are often abnormal in patients with CF, reflecting inflammation and/or infection, rather than actual iron stores. …”
    Get full text
    Article
  3. 183

    Dietary Flaxseed Oil Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats by Joshua Lawrenz, Betty Herndon, Afrin Kamal, Aaron Mehrer, Daniel C. Dim, Cletus Baidoo, David Gasper, Jonathan Nitz, Agostino Molteni, Richard C. Baybutt

    Published 2012-01-01
    “…Bleomycin, a widely used antineoplastic agent, has been associated with severe pulmonary toxicity, primarily fibrosis. Previous work has shown a reduction in bleomycin-induced lung pathology by long-chain omega-3 fatty acids. …”
    Get full text
    Article
  4. 184
  5. 185
  6. 186

    Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study. by Wenying Guo, Ting Weng, Yufei Song

    Published 2024-01-01
    “…To evaluate the relationship between serum selenium concentrations and the prevalence of MASLD and liver fibrosis, we employed a comprehensive multivariable analysis. …”
    Get full text
    Article
  7. 187

    Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor by Eric E. Essick, Flora Sam

    Published 2011-01-01
    “…Furthermore, we discuss findings from our laboratory that suggest that cardiac hypertrophy and fibrosis in the metabolic syndrome may involve cross-talk between aldosterone and adipokines (such as adiponectin).…”
    Get full text
    Article
  8. 188
  9. 189

    Liver fibrosis stage classification in stacked microvascular images based on deep learning by Daisuke Miura, Hiromi Suenaga, Rino Hiwatashi, Shingo Mabu

    Published 2025-01-01
    “…Abstract Background Monitoring fibrosis in patients with chronic liver disease (CLD) is an important management strategy. …”
    Get full text
    Article
  10. 190
  11. 191
  12. 192
  13. 193

    Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis by Premal Patel, Harvey R. Rabin, Michael M. Vickers, Michael D. Parkins

    Published 2013-01-01
    “…We report a case of metastatic bladder cancer developing in a young man with cystic fibrosis (CF) that was initially diagnosed as ureterolithiasis and managed as renal colic. …”
    Get full text
    Article
  14. 194

    Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis by Dongxu Lin, Mengyang Zhang, Changcheng Luo, Pengyu Wei, Kai Cui, Zhong Chen

    Published 2022-01-01
    “…Inhibition of ferroptosis using DFO and EDA represented a promising approach for treating prostatitis by ameliorating inflammation, fibrosis, and mast cell activation.…”
    Get full text
    Article
  15. 195

    Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis by Jingxue Han, Jingyi Hou, Yu Liu, Peng Liu, Tingting Zhao, Xinwei Wang

    Published 2022-01-01
    “…The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. …”
    Get full text
    Article
  16. 196

    Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD by Andrew D Schreiner, William P Moran, Jingwen Zhang, Patrick D Mauldin, Justin Marsden, Mulugeta Gebregziabher, Chelsey A Petz, David G Koch, Chloe Bays

    Published 2024-07-01
    “…Objective We aimed to determine the association of statins with progression to a high risk for advanced fibrosis in primary care patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Design This retrospective cohort study of electronic health record data included patients with MASLD and an initial low or indeterminate risk for advanced fibrosis, determined by Fibrosis-4 Index (FIB-4) score (<2.67). …”
    Get full text
    Article
  17. 197

    Scoping review: relationship between glucose tolerance and pulmonary decline in cystic fibrosis by Raina Tomoda, Deborah Jane Holmes-Walker

    Published 2024-10-01
    “… Cystic fibrosis-related diabetes (CFRD) causes deterioration of cystic fibrosis (CF) lung disease, thereby increasing mortality. …”
    Get full text
    Article
  18. 198
  19. 199
  20. 200

    Additive Effect of Dornase Alfa and Nacystelyn on Transportability and Viscoelasticity of Cystic Fibrosis Sputum by Feng Sun, Shusheng Tai, Thomas Lim, Ulrich Baumann, Malcolm King

    Published 2002-01-01
    “…OBJECTIVE: To investigate the effect of dornase alfa (DA), Nacystelyn (NAL) and their combination on mucociliary transportability and mucus viscoelasticity of cystic fibrosis (CF) sputum, and to assess whether the combination possesses an additive effect.…”
    Get full text
    Article